Jay T. Backstrom

Vice-Président Exécutif, Recherche et Développement

Acceleron Pharma IncScholar Rock Holding Corp Agios Pharmaceuticals, Inc.

Insider activity · 24 months0 buys2 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 1 saleFeb 25 · 0 buys · 1 saleMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Companies

▲ Purchases (0 ops.)

—

▼ Sales (3 ops.)

€1.8M

Latest filing published 10 Jul 2026 for AGIOS PHARMACEUTICALS, INC..

Filing timeline

BuySale

Jay T. Backstrom

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Jay T. Backstrom: trading record in brief

Jay T. Backstrom is a declared insider at 3 companies (senior executive); the most frequent names are Scholar Rock Holding Corp, Acceleron Pharma Inc and Agios Pharmaceuticals, Inc. Over a trading history stretching from 2 January 2020 to 8 July 2026, the count stands at 11 filings.

Every open-market trade on record is a sale: 3 sales worth €1.8M. The rest of the record consists of 7 share grants.

The latest filing, published on 10 July 2026, reports a share grant in Agios Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.